Top 50 Medical Device Startup Investors in China in April 2025

Investor	Medical Device China investments
Cowin Capital	12
HSG	12
Qiming Venture Partners	11
BioVenture	10
CD Capital	10
Lilly Asia Ventures	9
BIOCHING CAPITAL	9
Haibang Capital	8
Med-Fine Capital	7
Legend Capital	7
Dalton Venture	7
Shunwei Capital	7
IDG Capital	7
Prox Ventures	7
Jan Hammer	7
BioTrack Capital	7
Taiyu Investment	6
Addor Capital	6
Marathon Venture Partners	6
Matrix Partners China	6
Share Capital	6
SND Ventures Group	5
SZHTI Group	5
Goldport Capital	5
Sunland Fund	5
Apricot Capital	5
Fortune Venture Capital	4
Volcanics Venture	4
Insight Capital	4
EFung Capital	4
Qiaojing Capital	4
Taiyu Investment	4
Frees Fund	4
Huagai Capital	4
ASBV	4
HY Capital	4
CDH Investments	4
Oriza Holdings	4
Highlight Capital	4
Oriza Seed Capital (Oriza Yuandian)	3
Jolmo Capital	3
Co-Stone Venture Capital	3
Tsinghua Innovation Ventures	3
CMB International Capital Corporation	3
Lightspeed China Partners	3
Tasly Capital	3
Redhill Capital	3
Oriental Fortune Capital	3
BGI Co-Win	3
Legend Star	3

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.

Investment focus

Manufacturing, Health Care, Software
Series A, Series B, Angel
China, Hong Kong, United States

Portfolio highlights

Pure Water No.1 — Pure Water No.1 is a high-tech enterprise specializing in the design, manufacturing, installation, marketing, operation and service of pure water, ultrapure water, recycled water reuse, sewage treatment, waste gas treatment and seawater desalination systems.
Bandu Technology — Bandu Technology developed immersive 3D light field displays that use AI and big data to transform human connectivity and engagement. It focuses on the intelligent presentation and management of images and data, enabling industrial evolution, creating unlimited industrial space, and creating a new experience for human life.
Damo Intelligent Control — Damo Intelligent Control is a national specialized "little giant" enterprise and a national high-tech enterprise focusing on the research and development, production, sales, and service integration of drone cluster automation performance systems. It is the world's leading supplier of drone cluster automation performance systems.

We help founders build enduring companies.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Manus AI — Manus is a general AI agent that bridges thoughts and actions by excelling in various tasks such as research, data analysis, education, and productivity, offering personalized solutions across different domains to help users achieve their goals efficiently.
RedotPay — RedotPay is a leading crypto fintech bridging Web3 and traditional finance through innovative, cost-efficient blockchain solutions. Our intuitive crypto payment products enable millions of users globally to easily spend and send digital assets. We foster financial inclusion for the unbanked and serve crypto enthusiasts, advancing global adoption offast, accessible crypto payments.
Danking Pharmaceuticals — Danking Medicine is an innovation-driven drug developer.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
Xinzeyuan Medical — Xinzeyuan Medical is a manufacturer of key precision components and medical endoscope consumables.
Iongen Therepeutics — Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
Hengyu Medical — Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.
MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Seed
China, United States

Portfolio highlights

Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.

BIOCHING CAPITAL is an investment management firm.

Investment focus

Medical Device, Biotechnology, Medical
Angel, Series A, Seed
China

Portfolio highlights

Taose Tuantuan — Taose Tuantua is a sex toy company that primarily offers TAOSETT sex toy academy and exquisite sex toy community store services.
Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Angel, Series B
China

Portfolio highlights

MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
China, United States

Portfolio highlights

ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
BV Laser — BV Laser is a manufacturer of medical beauty equipment.
Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

Picea Motion — Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.
AiCheng Technology — Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.
TBSTest Technology — Yuexin Technology is a semiconductor test equipment developer specializing in R&D, production and sales of ultra-large-scale integrated circuit test equipment (ATE). Its main product is SOC test equipment, which is mainly for enterprise users of integrated circuit design, production, packaging and testing. Integrated circuit test equipment andsolutions.

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Investment focus

Health Care, Medical, Medical Device
Seed, Series A, Series B
India, China, Canada

Portfolio highlights

LegitQuest — An online legal research platform with Indian case laws. Research on Indian Cases, Judgments & Acts with AI enabled, User friendly product features.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.Shunwei Capital is a China-based company that was founded in 2011 by Tuck Lye Koh and Lei Jun.

Investment focus

Manufacturing, Internet, Software
Series A, Series B, Series C
China, India, United States

Portfolio highlights

Hohem — Hohem is a world-leading brand dedicated to AI tracking gimbals for video shooting, providing consumer and professional stabilizers for smartphones and cameras.
P.A.I Tech — P.A.I Tech is an intelligent tool that supports the efficiency and accuracy of document work throughout the entire process. They create data platforms in the community for reading financial texts. Their business primarily focuses on creating platforms for big data and artificial intelligence-based financial text-reading, which increases userproductivity in financial work.
Guanchen Biotechnology — Guanchen Biotechnology is a developer of innovative cosmetic ingredients.

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

Investment focus

Software, Internet, E-Commerce
Series A, Series B, Series C
China, United States, India

Portfolio highlights

ChainOpera AI — ChainOpera AI - The Blockchain and Protocol for Co-owning and Co-creating Decentralized AI Apps and Agents for Humanity, Backed by Federated AI OS and Platform
Xinyanyi Code — Xinyanyi Code is an artificial intelligence programming application service provider that focuses on AI Coding and benchmarks the American intelligent code generation product Cursor.
Yin Gong Technology — Yin Gong Technology develops energy storage technology. It is an innovative battery technology developer in the green technology field.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Seed, Funding Round, Series A
China, United States, United Kingdom

Portfolio highlights

Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.
Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.

Jan joined Index in 2010, and is a London-based partner, focusing on fintech and information/data services across all stages of growth.He is one of Index Ventures’ leading fintech investors, working with the founders of Adyen, Credit Benchmark, Robinhood and TransferWise. In all, Index has backed more than two dozen fintech companies, withmore than $400 million. Jan has also led Index investments and is on the boards of Beamery, Collibra, SafetyCulture and Silverfin.Before he joined Index, Jan was at General Atlantic in London, where he worked on investments in Kaspersky Lab, Northgate Information Solutions and Torex Retail. He also worked in the M&A, TMT and Capital Markets divisions at Morgan Stanley. Jan is a graduate of Oxford University, and holds an MBA with Distinction from INSEAD.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China, United States, United Kingdom

Portfolio highlights

MacroLux — MacroLux operates as a medical technology company focusing on endoscopic interventional business. MacroLux develops endoscopic interventional therapy solutions and promote them to the majority of medical customers.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.

BioTrack Capital is a China-based investment firm.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Singapore

Portfolio highlights

Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
Rona Therapeutics — Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.
Moyang Biotechnology — Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.

Taiyu Investment is an investment firm.

Investment focus

Medical, Medical Device, Biotechnology
Series A, Angel, Seed
China

Portfolio highlights

NeuroPlus — NeuroPlus is a developer of bioelectric sensing technologies, with an emphasis on new applications such as precise EEG measurement, smart wearables, and mobile medical care.
Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

Investment focus

Manufacturing, Electronics, Semiconductor
Series A, Series B, Funding Round
China, Hong Kong, United States

Portfolio highlights

Vulcan — Vulcan is an engineering ceramics technology company that specializes in manufacturing mechanical seals and its materials.
Xingwei Technology — Xingwei Technology is a high-tech enterprise focusing on high-end equipment, develops and manufactures high-performance Machine equipment and motion control systems. .
Chasing Light Technology — Chasing Light provides organic semiconductor technology designed for the photovoltaic industry. Their organic semiconductor materials and their optoelectronic devices have shown application potential in the semiconductor field due to many advantages such as low cost, easy performance adjustment, flexibility, thinness, and transparency.

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Angel
China, United States, Hong Kong

Portfolio highlights

Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
Kangai Medical — Kangai Medical specialises on clinical nutrition and rehabilitation
Femtosecond Technology — Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

LeXiang Intelligence — LeXiang Intelligence is a robotics company that specializes in the development of intelligent consumer-grade robots.
Zhongcheng Technology — Zhongcheng Technology is a centralized lubrication system developer that focuses on the research and development, manufacturing, sales, and technical services of centralized lubrication systems.
Titanium Robotics Technology — Titanium Robotics Technology specializing in the development and production of advanced robot hardware and solutions. It focuses on customized services, R&D, and production of robot hardware, aiming to create high-performance, industry standard products, develops lightweight, collaborative robots, humanoid robots, and exoskeletons, leading thesupply chain towards lightweight, miniaturization, and ease of use.

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Colombia

Portfolio highlights

Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.

SND Ventures Group is a venture capital and private equity firm specializing in seed investments.

Investment focus

Manufacturing, Semiconductor, Health Care
Series A, Series B, Seed
China

Portfolio highlights

Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
Kunlun Precision — Kunlun Precision is a laser precision manufacturing service provider that focuses on the design integration and control system development of laser extreme advanced manufacturing equipment and devices, as well as supplying cross-scale laser manufacturing systems.
AiCheng Technology — Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.

SZHTI Group is a company that provides asset management and financing services.

Investment focus

Manufacturing, Electronics, Semiconductor
Series A, Angel, Funding Round
China, United States

Portfolio highlights

StarDetect — StarDetect is a space-based computing platform that provides full-process satellite-based intelligent application service solutions.
Sanyuan Aerospace — Sanyuan Aerospace is an aerospace service provider with a core business in space operation technologies, space operation-related equipment development, and space on-orbit service business operations.
Damo Intelligent Control — Damo Intelligent Control is a national specialized "little giant" enterprise and a national high-tech enterprise focusing on the research and development, production, sales, and service integration of drone cluster automation performance systems. It is the world's leading supplier of drone cluster automation performance systems.

Goldport Capital is a Shenzhen-based asset management company.

Investment focus

Manufacturing, Medical, Semiconductor
Series A, Seed, Series B
China

Portfolio highlights

Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
Chaoguang Micro — Chaoguang Micro specializes in the innovative development of optical products for medical and industrial purposes.
Teyan Semiconductor — Taiyan Semiconductor is a semiconductor process and equipment service provider in the field of advanced packaging. It provides customers with advanced packaging production lines such as SiP, Fanout, Chiplet, 3D, etc. Laser (laser) + Plasma (plasma) + Sputter (coating) complete composite process and Process application equipment.

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China

Portfolio highlights

JH Cispoly — JH Cispoly develops diagnostic technology and equipment for gynecological tumors.
Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.

Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
China, United States, Hong Kong

Portfolio highlights

Zhonghe Gene — Zhonghe Gene is a gene technology developer, primarily involved in the research and development of DNA biosynthesis technology.
Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
Simcere Pharma — Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a researchand development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million.

Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.

Investment focus

Manufacturing, Information Technology, Software
Series A, Series B, Seed
China, Japan, United States

Portfolio highlights

TRUGO TECH — TRUGO TECH focuses on the research, development, and manufacturing of wire-controlled chassis. ESC and ABS are the main products of QianGu Technology
Picea Motion — Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.
Zipingfang Gufen — Zipingfang Gufen provides artificial intelligence voice interactive robots and solutions.

Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Seed
China, United States

Portfolio highlights

Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .

Insight Capital is a venture capital firm focused on early-stage investment.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Series C
China

Portfolio highlights

Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.
Iongen Therepeutics — Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment.

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.

Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Angel
China

Portfolio highlights

Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.

Taiyu Investment is an investment firm.

Investment focus

Medical, Health Care, Biotechnology
Series A, Seed, Angel
China

Portfolio highlights

Immorna — Immorna specializes in the production of RNA-based therapeutics.
ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Investment focus

Artificial Intelligence, Medical, Biotechnology
Series A, Seed, Angel
China, United States, Singapore

Portfolio highlights

XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
Dezao Technology — Dezao Technology is an e-commerce transaction provider, mostly involved in the sales of electronic products, mobile phones, and mobile phone accessories.
Yuanluo Technology — Yuanluo Technology is committed to providing innovative robotic solutions across multiple industries, including health, logistics, and service sectors.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Germany

Portfolio highlights

Amazinc — Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.
ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.

ASBV focuses on early and mid-term venture capital investments.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Angel
China, Australia, Hong Kong

Portfolio highlights

Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.

HY Capital is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments.

Investment focus

Health Care, Medical, Medical Device
Series A, Seed, Series B
China, United States

Portfolio highlights

Kang Ruijian — Kang Ruijian is a developer of thermosensitive modified chitin hydrogel technology.
Onico Medical — Onico Medical is a medical device developer. The core team comes from the serious medical field and has absorbed professionals with rich experience in medical aesthetics development.
Linyan Medical — Linyan Medical is a high-tech company focusing on the combination of man and machine in metaverse medical surgery.

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Investment focus

Manufacturing, Biotechnology, Health Care
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
Mingxin Digital — Mingxin Digital is a financial technology company dedicated to driving industrial credit management with digital technology.
Zhongtiansheng New Materials — Zhongtiansheng New Materials is a polyimide monomer and resin production company. It also manufactures resin material composites and liquid crystal orientation agents.

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

Investment focus

Health Care, Manufacturing, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

Yuanluo Technology — Yuanluo Technology is committed to providing innovative robotic solutions across multiple industries, including health, logistics, and service sectors.
Jinke Machine Tools — Jinke Machine tools specializes in manufacturing intelligent machine tools and industry solutions.
Jiongyi Electronics — Jiongyi Electronics is a developer of automotive brake products, focusing on the development of automotive brake product technology.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Portugal

Portfolio highlights

ENGINEAI — ENGINEAI is committed to advancing the commercialization of humanoid robot technology worldwide.
Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.

Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Seed, Angel
China, United States

Portfolio highlights

Zhongke Bosheng — Zhongke Bosheng develops and manufactures thermoelectric semiconductor materials for vehicle temperature control.
AiCheng Technology — Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.
Femtosecond Technology — Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.

Jolmo Capital is an investment firm that provides related capital management and advisory services to new industries. As a diversified firm, Jolmo helps assist enterprises with rapid growth primarily through venture capital and in collaboration with other financial instruments.Jolmo Capital was founded in 2004 and is based in Nanjing, JiangsuProvince in China.

Investment focus

Health Care, Manufacturing, Medical
Series A, Seed, Series B
China, Japan, United States

Portfolio highlights

Tuohang Technology — Tuohang Technology is a heavy-lift unmanned helicopter developer that focuses on the study, design, manufacture, and distribution of unmanned helicopters for both military and civilian applications.
Erui Micro Semiconductor — Erui Micro Semiconductor is a semiconductor company that specializes in the development of semiconductor overlay front-end measurement equipment.
Deli Smart Logistics Technology — Deli Smart Logistics Technology is a smart warehousing logistics system and equipment integrator specializing in smart manufacturing and logistics.

Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China's earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chineseeconomy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products & services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing，Shanghai and Hefei.

Investment focus

Manufacturing, Semiconductor, Health Care
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

HONOR — Established in 2013 by Huawei, Honor is a leading global provider of smart devices. We are committed to becoming a global iconic tech brand and enabling a smart life across all scenarios and all channels, for all people. With a strategic focus on innovation, quality and service, honor is dedicated to developing technology that empowers peoplearound the globe to go beyond through its R&D capabilities and forward-looking technology, as well as creating a new intelligent world for everyone with its portfolio of innovative products.
Metrono — Metrono is a manufacturer of cable and optical cable that provides high-performance rail transit special cable solutions and supplies a full range of European standard locomotive cables.
X Square — X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.

Tsinghua Innovation Ventures is an investment management firm.

Investment focus

Medical, Manufacturing, Health Care
Funding Round, Series A, Angel
China

Portfolio highlights

ENCOS — ENCOS is a developer of high-performance robot integrated joint modules. The company focuses on matters of embodied intelligence, with robot reduction motors as its main business.
Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
Coretech Technologies — Coretech Technologies is a company that creates sophisticated sensors and novel materials for new power systems.Coretech Technologies primary focus is on the research, development, and production of intelligent sensors and innovative materials for new power systems and energy digital transformation.

CMB International Capital Corporation is an investment banking firm that offers comprehensive professional services and financial advisory services. It provides mergers and acquisitions, initial public offering, equity underwriting, company restructuring, project financing, and business consulting services. CMB International Capital Corporationprovides corporate finance, asset management, wealth management and securities brokerage services. Additionally, it offers debt financing and transaction advisory services, placement of shares and refinancing for listed companies. CMB International Capital Corporation’s clientele include institutional, corporate and individual customers both domestic and overseas. It began operation in 1987, with its headquarters in Central in Hong Kong as a subsidiary of China Merchants Bank.

Investment focus

Biotechnology, Manufacturing, Health Care
Series B, Series A, Series C
China, United States, Japan

Portfolio highlights

Aiper — Pool cleaners of all types have been around as long as there have been pools; Aiper is the new kid on the block with a lot to prove. How would we make up the gap? By constantly innovating, throwing everything we have into R&D to raise the quality of your pool at every level. We do every test, have developed dozens of sensors and hundreds ofalgorithms, all ageared to making your pool experience the best, most effortless experience possible – that is the Aiper promise. With over one million dollars in crowdfunding, more than any other cordless robotic pool cleaning product, people are taking notice.
Damo Intelligent Control — Damo Intelligent Control is a national specialized "little giant" enterprise and a national high-tech enterprise focusing on the research and development, production, sales, and service integration of drone cluster automation performance systems. It is the world's leading supplier of drone cluster automation performance systems.
NAEN Auto Technology — Shanghai NAEN Auto Technology co.Ltd provides automotive electronics products for automobile manufacturers.

Lightspeed China Partners is a leading Chinese venture capital firm focusing on early-stage investments. We are the Chinese partners to Lightspeed Venture Partners. Our expertise is in mobile, Internet, technology-enabled services, and enterprise solution companies. We currently manage three USD funds and one RMB fund.Lightspeed China Partners isalso a young team. We value equality, respect and fairness. Our culture reflects our focus, drive for excellence, and our win-win approach to business.We are dedicated to identifying the next generation of entrepreneurial leaders. To accomplish this , we analyze trends, work with creative teams, and undertake joint efforts to pursue early-stage investments. We are honored to help entrepreneurs because your dream is the greatest thing in the world.

Investment focus

Manufacturing, Internet, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

X Square — X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.
Infrawaves — Infrawaves is a next Generation High-Performance Network System.
Zhefei Aviation — Zhefei Aviation specializes in providing airworthy avionics, including the IVOS flight control software system and the EPS energy system.

Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.

Investment focus

Health Care, Medical, Medical Device
Series B, Seed, Series A
China

Portfolio highlights

EurekaBio — EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.
PulseCare — PulseCare is a medtech company that specializes in innovative medical devices and solutions for cardiac and pan-vascular treatment.
Deco Medical — Deco Medical is a myocardial repair service provider and an innovative medical device research and development enterprise.

Redhill Capital is a venture capital firm specializing in early stage investment. It primary invests in medical industry.

Investment focus

Health Care, Biotechnology, Medical
Seed, Series A, Funding Round
China

Portfolio highlights

Douli — Douli is an employee service platform that provides welfare solutions for enterprises. They offer services in the fields of clothing, food, housing, transportation, medical care, entertainment, and more by combining online and offline multi-channel resources.
Inflamax Pharmaceuticals — Inflamax Pharmaceuticals is a biomedical technology company that specializes in the innovation and development of immune-inflammatory drugs.
EnCureGen Pharmaceuticals — Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Manufacturing, Information Technology
Series A, Series B, Seed
China, United States

Portfolio highlights

Mufan Power — Mufan Power is a new energy high-tech enterprise in the field of turbomachinery. It is committed to the development of a new generation of zero-carbon hydrogen power generation technologies and products. Its main products are hydrogen gas turbines, which can be used in distributed energy and data centers. , rail transit, ship power, vehicle power,energy storage peak shaving and other carbon neutral scenarios.
Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT

BGI Co-Win is the corporate venture capital arm of BGI and is based in Shenzhen, China.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Seed, Angel
China

Portfolio highlights

LeadBio Tech — LeadBio Tech is a biotechnology company that specializes in the development of bioartificial blood vessel medical devices.
Yingshu Life — Yingshu Life is a research and development manufacturer of minimally invasive medical devices.
Waker Biology — Weike Bio is a gene therapy drug development company.

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Angel
China, United States, France

Portfolio highlights

BlueSky Aviation — BlueSky Aviation focuses on the research and development of electric vertical take-off and landing aircraft.
Primus Labs — Primus connects Web2 data to Web3, offering verified information to AI models while ensuring user privacy.
Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.